AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Etiq 0.25 Orally Disintegrating Tablet

Prescription Icon
Prescription Required

Marketer

Novosys Life Sciences Private Limited

Salt Composition

Etizolam (0.25mg)

Overview Etiq 0.25 Orally Disintegrating Tablet

Solara 0.25mg orally disintegrating tablets are a prescription medication for short-term anxiety and sleeplessness. Working by binding to specific brain receptors, it promotes calmness and relaxation. Solara 0.25mg may be taken with or without food, but consistent daily timing ensures stable blood levels. Follow your doctor's prescribed dosage and duration precisely, as this medication has a high potential for dependence. If a dose is missed, take it immediately upon recollection and complete the entire course, even if symptoms improve. Discontinuing the medication without consulting your physician may trigger nausea and anxiety. Potential side effects include headaches, motor incoordination, slurred speech, muscle weakness, changes in libido, and depression. Dizziness and drowsiness are also possible; avoid driving or tasks requiring alertness until the medication's effects are known. Discuss any side effects and management strategies with your doctor. Withdrawal symptoms may occur after treatment cessation. Inform your physician if you are pregnant, planning pregnancy, or breastfeeding before commencing treatment. While Solara 0.25mg generally interacts safely with other medications, some substances, including antacids and alcohol, can alter its efficacy and increase adverse effects. Prolonged use may necessitate regular blood and liver function monitoring.

Uses of Etiq 0.25 Orally Disintegrating Tablet

Managing brief anxiety episodes | Addressing short-term sleep difficulties

Major Benefits of Etiq 0.25 Orally Disintegrating Tablet:

Administer this medication according to your physician's prescribed dosage and schedule. Avoid handling the tablets with damp hands. Place the tablet in your mouth; refrain from swallowing immediately. Etiq 0.25 Orally Disintegrating Tablets can be consumed with or without food, although consistent timing is recommended.

Common Side effects of Etiq 0.25 Orally Disintegrating Tablet:

  • Altered libido
  • Confusion
  • Depression
  • Drowsiness
  • Fainting
  • Headache
  • Muscle coordination impaired
  • Muscle weakness
  • Sedation
  • Slurred speech
  • Tremors
  • Visual impairment

How to use Etiq 0.25 Orally Disintegrating Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Avoid touching the tablets with damp hands. Place the Etiq 0.25 Orally Disintegrating Tablet in your mouth; do not ingest it immediately. This medication can be taken with or without food, although consistent timing is recommended.

How Etiq 0.25 Orally Disintegrating Tablet works:

Etiq 0.25mg orally dissolving tablets contain a benzodiazepine that enhances the effects of GABA, a neurotransmitter. This action reduces heightened, irregular neuronal firing in the brain.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Consuming alcohol while taking Etiq 0.25 Orally Disintegrating Tablets may be unsafe; seek medical advice before doing so.

PregnancyPregnancyCONSULT YOUR DOCTOR

Data on the use of Etiq 0.25 orally disintegrating tablets in pregnancy is lacking. Seek medical advice from your physician.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Data on the use of Etiq 0.25 orally disintegrating tablets while breastfeeding is lacking. Seek medical advice from your physician.

DrivingDrivingUNSAFE

Taking Etiq 0.25 Orally Disintegrating Tablets may lead to adverse reactions that could compromise your driving safety. Sedation and musculoskeletal relaxation are frequently reported side effects of this medication, potentially affecting your ability to operate a vehicle.

KidneyKidneyCONSULT YOUR DOCTOR

Insufficient data exists regarding the use of Etiq 0.25 orally disintegrating tablets in individuals with renal impairment. Seek medical advice from your physician.

LiverLiverCONSULT YOUR DOCTOR

Insufficient data exists regarding the administration of Etiq 0.25 orally disintegrating tablets to individuals with hepatic impairment. Seek medical advice.

What if you forget to take Etiq 0.25 Orally Disintegrating Tablet :

Should you forget a dose of Etiq 0.25 orally disintegrating tablets, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Etiq 0.25 Orally Disintegrating Tablet

LabelValue
Chemical Type Thienodiazepine Analog
Developing Habits No.
Treatment Category Neuroscience
Behavior Class Benzodiazepine medications

FAQs on Etiq 0.25 Orally Disintegrating Tablet

Reports indicate a potential for Etiq 0.25 Orally Disintegrating Tablets to be misused; cautious use is advised in abuse-prone patients.
Etiq 0.25 Orally Disintegrating Tablets exhibit reduced sedative effects, lower dependence potential, and slower tolerance development compared to other benzodiazepines. Nevertheless, prolonged use may diminish efficacy and carry a risk of dependence and addiction.
Abruptly discontinuing Etiq 0.25 Orally Disintegrating Tablets can trigger withdrawal, potentially causing anxiety, insomnia, headache, dizziness, tinnitus, anorexia, vomiting, nausea, tremor, weakness, excessive sweating, irritability, and heightened sensitivity to sights and sounds. Sudden cessation may also lead to palpitations, tachycardia, and postural hypotension. Severe, rare cases involving high doses may result in seizures, psychosis, agitation, confusion, and hallucinations.
Etiq 0.25 Orally Disintegrating Tablets take effect within 30 to 60 minutes after oral administration, reaching peak levels in 3 to 4 hours. The medication's effects typically last 6 to 8 hours, though this may be extended with higher doses.
While it shares benzodiazepines' muscle relaxant property, its primary application is in anxiety treatment.
Primarily prescribed for anxiety, this benzodiazepine, like others, induces drowsiness. While it extends total sleep duration and reduces REM sleep, it doesn't impact sleep onset time.
Etiq 0.25 Orally Disintegrating Tablets are not antidepressants; they treat generalized anxiety disorder with depressive symptoms, although they can influence mood.
Etiq 0.25 Orally Disinteg...
29
MRP 33
12% off